Filters

Factor D/Adipsin Antibody, Cy7 Conjugated

Factor D/Adipsin Antibody, Cy7 Conjugated size: 0.1ml 350

Price 350
Size 0.1ml
Long name Cy7 Conjugated, Factor D/Adipsin Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationCy7
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenFactor D/Adipsin
SpecificityThis is a highly specific antibody against Factor D/Adipsin
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
Immunogen_range20-70/253
Subcellular locationSecreted
SourceKLH conjugated synthetic peptide derived from human Factor D/Adipsin
Gene ID number1675
Swiss ProtP00746
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
Crossreactivity Mouse, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background Its function is homologous to that of C1s in the classical pathway, activating the C3bbb complex, which then becomes the C3 convertase of the alternate pathway, Factor D cleaves factor B when the latter is complexed with factor C3b
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission743nm/767nm
Synonyms ADIPSIN, ADN, C3 convertase activator, CFD, Complement factor D, PFD, Properdin factor D, DF
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
ConjugatedThese antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths
Gene targetFactor D/Adipsin Conjugated
Short name Conjugated, Factor D/Adipsin Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelCy7
Alternative name cyanine 7 coupled, Factor D/Adipsin (Antibody to)
Alternative techniqueantibodies

Subscribe to our Newsletter